Associated Papers
JAK2 mutational status and the contribution of TERT and JAK2 polymorphisms to the occurrence of myeloproliferative neoplasms in Eastern Morocco.
Belmokhtar KY et al.
African Health Sciences, 2024
Diagnosis of exon 12-positive polycythemia vera rescued by NGS.
Geay A et al.
Clinical Case Reports, 2020
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.
Godfrey AL et al.
Blood, 2012
A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders.
Hamidah NH et al.
La Clinica Terapeutica, 2012
The JAK2 exon 12 mutations: a comprehensive review.
Scott LM
American Journal of Hematology, 2011
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
Schnittger S et al.
Haematologica, 2009
Select a paper to view details